U.S. Markets open in 8 hrs
  • Gold

    1,774.90
    +4.40 (+0.25%)
     
  • EUR/USD

    1.1651
    +0.0014 (+0.1165%)
     
  • 10-Yr Bond

    1.6350
    0.0000 (0.00%)
     
  • Vix

    15.70
    -0.61 (-3.74%)
     
  • GBP/USD

    1.3803
    +0.0009 (+0.0663%)
     
  • USD/JPY

    114.5590
    +0.1990 (+0.1740%)
     
  • BTC-USD

    63,913.81
    +1,505.79 (+2.41%)
     
  • CMC Crypto 200

    1,481.16
    +17.80 (+1.22%)
     
  • FTSE 100

    7,217.53
    +13.70 (+0.19%)
     
  • Nikkei 225

    29,274.12
    +58.60 (+0.20%)
     

SHAREHOLDER ALERT: OCGN DKNG CXO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / August 4, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Ocugen, Inc. (NASDAQ:OCGN)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/ocugen-inc-loss-submission-form?prid=18231&wire=1
Lead Plaintiff Deadline: August 17, 2021
Class Period: February 2, 2021 - June 10, 2021

Allegations against OCGN include that: (i) the information submitted to the U.S. Food and Drug Administration ("FDA") was insufficient to support an Emergency Use Authorization ("EUA"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp. (NASDAQ: DKNG)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/draftkings-inc-f-k-a-diamond-eagle-acquisition-corp-loss-submission-form?prid=18231&wire=1
Lead Plaintiff Deadline: August 31, 2021
Class Period: December 23, 2019 - June 15, 2021

Allegations against DKNG include that: (i) SBTech Global Limited ("SBTech"), a company acquired by DraftKings, had a history of unlawful operations; (ii) accordingly, DraftKings' merger with SBTech exposed the Company to dealings in black-market gaming; (iii) the foregoing increased the Company's regulatory and criminal risks with respect to these transactions; (iv) as a result of all the foregoing, the Company's revenues were, in part, derived from unlawful conduct and thus unsustainable; (v) accordingly, the benefits of the Business Combination were overstated; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Concho Resources Inc. (NYSE:CXO)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/concho-resources-inc-loss-submission-form?prid=18231&wire=1
Lead Plaintiff Deadline: September 28, 2021
Class Period: February 21, 2018 - July 31, 2019

Allegations against CXO include that: (1) the well spacing at Dominator was aggressive and highly risky, and premised on no reasonable basis to believe it would work as intended; (2) Concho's practice of implementing tighter well spacing was not relegated to a handful of "tests" and therefore more widespread than the market was led to believe; (3) it was known or recklessly disregarded that any measures to mitigate well spacing risks were non-existent and or/impossible; (4) these risks had manifested during the Class Period, causing underground well interference and permanently decreasing production, forcing the Company to scale back production targets and adopt more conservative spacing measures in its other projects; (5) it would take multiple quarters to unwind the impacts of the widespread well spacing failure; and (6) as a result of the foregoing, the Company's public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/658405/SHAREHOLDER-ALERT-OCGN-DKNG-CXO-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines